by Richard Daverman, PhD
August 9, 2012 -- Takeda Pharma, the largest pharma in Japan, has officially opened its new headquarters for clinical trials in China, called the Takeda Shanghai Development Center. The new facility will be responsible for Takeda’s general medicine clinical trials in China and oncology treatments across Asia. The company said the new facility underscores its commitment to Asia and China in particular. More details....
Stock Symbol: (TSE: 4502)
